0
Article Sign in to save

Micro- and nanoplastics influences in Parkinson’s disease: lessons from human stem cell models

AI summary Read the abstract

Human stem cell models reveal that micro- and nanoplastics may worsen neuroinflammation in Parkinson's disease by promoting alpha-synuclein aggregation, microglial reactivity, and mitochondrial dysfunction in dopaminergic neurons. This research is significant because it provides human-relevant evidence that environmental microplastic exposure could accelerate or trigger neurodegenerative disease progression.

Body Systems
Models

Neuroinflammatory contributions play a critical role in Parkinson’s disease onset and progression. Key drivers of neuroinflammation include glial cell reactivity, cytokine signaling, protein aggregation, and mitochondrial dysfunction. Although animal models have been extensively used to investigate the mechanisms, their translational relevance is limited because neuroinflammation in humans is typically chronic, heterogeneous, and sustained over years, whereas in rodents is often acute, transient, and resolves within days to weeks. This paper highlights the utility of human stem cell–derived models in studying Parkinson’s disease by recapitulating patient-specific genetic mutations, neuroinflammatory microglia–neuron interactions, α-synuclein aggregation, and dopaminergic dysfunction, thereby enabling mechanistic studies in the human-relevant models. In addition, we examine how micro- and nanoplastics may exacerbate neuroinflammation in PD. This review concludes by highlighting how human-relevant stem cell-based approaches advance mechanistic understanding of Parkinson’s disease.

More Papers Like This

Article Tier 2

Micro-nanoplastics and Parkinson’s disease: evidence and perspectives

AI summary Read the abstract

Researchers reviewed growing evidence linking micro- and nanoplastic exposure to Parkinson's disease, a degenerative brain condition. Lab studies suggest these particles may accelerate disease by promoting the misfolding of a key brain protein (alpha-synuclein), triggering inflammation, and damaging mitochondria — though large-scale human studies are still needed to establish causation and define safe exposure thresholds.

Article Tier 2

Environmental Nanoplastic Accumulation and Neurodegenerative Disease in Animal Models

AI summary Read the abstract

This review examines animal model evidence linking environmental nanoplastic accumulation in brain tissue to neurodegeneration, synthesizing studies showing that nanoplastics trigger neuroinflammation, protein aggregation, and synaptic dysfunction relevant to Parkinson's and Alzheimer's disease pathology.

Article Tier 2

Microplastics and Nanoplastics as Potential Contributors to Neurodegenerative Disease: Mechanistic Links to Dementia, Parkinson's Disease, Epilepsy, and Emerging Therapeutic Opportunities

AI summary Read the abstract

Researchers reviewed emerging evidence that micro- and nanoplastics may contribute to neurodegeneration by promoting neuroinflammation, oxidative stress, blood-brain barrier disruption, and direct interactions with aggregation-prone proteins like amyloid-β and α-synuclein, proposing that pre-existing neurological disease may increase susceptibility to particulate accumulation in brain tissue.

Article Tier 2

Microplastics and Nanoplastics as Potential Contributors to Neurodegenerative Disease: Mechanistic Links to Dementia, Parkinson's Disease, Epilepsy, and Emerging Therapeutic Opportunities

AI summary Read the abstract

Researchers review how microplastics and nanoplastics may reach the brain via inhalation and systemic routes, proposing that chronic neuroinflammation, oxidative stress, and direct interactions with proteins like amyloid-β and α-synuclein could link particle exposure to Alzheimer's, Parkinson's, and other neurodegenerative conditions.

Article Tier 2

Plastamination in Human Brain: The Possible Role of Microplastics in Neuroinflammation and Parkinson’s Disease

AI summary Read the abstract

Tiny plastic particles from our environment can travel through the body and cross into the brain, where research suggests they may trigger inflammation and damage that's linked to Parkinson's disease. This review pulls together existing studies to show how these plastic particles might contribute to protein clumping in the brain similar to what's seen in Parkinson's patients, though scientists stress this connection is still being investigated and more research is needed. Still, it's a reminder that reducing plastic exposure in daily life (from food packaging, water bottles, and other sources) may be worth considering for long-term brain health.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper